This stock has held up really well. Meeting guidance is encouraging. Investors' focus hasn't been on uraniun with all the dramas elsewhere, but it should follow. Can't rule out the possibility of a corporate deal, maybe a takeout, given background of CEO.
- Forums
- ASX - By Stock
- Ann: Quarterly Activities Report for Period Ending 31 Dec 2015
This stock has held up really well. Meeting guidance is...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PDN (ASX) to my watchlist
(20min delay)
|
|||||
Last
$11.85 |
Change
0.070(0.59%) |
Mkt cap ! $3.544B |
Open | High | Low | Value | Volume |
$11.64 | $11.93 | $11.59 | $27.97M | 2.369M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 500 | $11.85 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$11.86 | 606 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 500 | 11.850 |
4 | 82857 | 11.800 |
2 | 15943 | 11.790 |
2 | 1868 | 11.780 |
3 | 44559 | 11.760 |
Price($) | Vol. | No. |
---|---|---|
11.930 | 1868 | 2 |
11.950 | 1000 | 1 |
11.970 | 9954 | 1 |
11.990 | 10105 | 3 |
12.000 | 4030 | 5 |
Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
Featured News
PDN (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online